title: A novelKRASgene mutation report in sporadic colorectal cancer, from Northwest of Iran.
abstract: While the role ofKRASgene mutations has been widely accepted for predicting responses to anti-EGFR therapy in patients with colorectal cancer, although this study was based on observation of a single case it gives hope that someKRASgene mutation may have favorable prognosis. More studies are required on patients with similar mutation to validate this finding.
authors.affiliation: Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran.
authors.forename: Roya
authors.initials: R
authors.lastname: Dolatkhah
authors.affiliation: Liver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.
authors.forename: Mohammad Hossein
authors.initials: MH
authors.lastname: Somi
authors.affiliation: Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran.
authors.forename: Iraj Asvadi
authors.initials: IA
authors.lastname: Kermani
authors.affiliation: The University of Kansas Medical School-Molecular Medicine Laboratory Kansas City Kansas USA.
authors.forename: Faris
authors.initials: F
authors.lastname: Farassati
authors.affiliation: Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran; Tabriz Health Services Research Center Tabriz University of Medical Sciences Tabriz Iran.
authors.forename: Saeed
authors.initials: S
authors.lastname: Dastgiri
keywords: Colorectal cancer; KRAS; mutation; sequencing